Showing results (31-40 of 224) with videos related to
Sort By:
Pageof 23
Cancer|October 6, 2010
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: Definitions and clinical implicationsJavier Pinilla-Ibarz, Jorge Cortes, Michael J MauroHematology. American Society of Hematology. Education Program|December 10, 2017
Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapyMary C Barber, Michael J Mauro, Javid MoslehiClinical Advances in Hematology & Oncology : H&O|June 4, 2014
Sequential therapy in chronic myelogenous leukemia: where do emerging therapies fit within current treatment regimens?Michael J Mauro, Moshe Talpaz, Jerald P RadichPhysical Review. E|November 15, 2016
Uniform asymptotic approximation of diffusion to a small target: Generalized reaction modelsSamuel A Isaacson, Ava J Mauro, Jay NewbyMethods in Molecular Biology (Clifton, N.J.)|December 16, 2020
Classification of Long Noncoding RNAs by k-mer ContentJessime M Kirk, Daniel Sprague, J Mauro CalabreseClinical Lymphoma, Myeloma & Leukemia|December 25, 2017
Considerations for Successful Treatment-free Remission in Chronic Myeloid LeukemiaStuart L Goldberg, Michael Savona, Michael J MauroACG Case Reports Journal|August 23, 2024
Gastrointestinal Follicular Lymphoma of the Cecum Treated via Endoscopic Full-Thickness ResectionAnthony J Mauro, Phoenix D Bell, Kevin McGrathPoultry Science|March 24, 2010
Regulation of chick bone growth by leptin and catecholaminesL J Mauro, S J Wenzel, G M SindbergCancer Investigation|August 7, 2003
STI571 as a targeted therapy for CMLMichael E O'Dwyer, Michael J Mauro, Brian J DrukerClinical Advances in Hematology & Oncology : H&O|March 14, 2015
Integrating current treatment options for TKI-resistant chronic myeloid leukemiaJerald P Radich, Neil P Shah, Michael J MauroPageof 23